Ticker Details
Neumora Therapeutics, Inc.
IPO Date:	September 15, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$305.72M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 4.31%
Avg Daily Range (30 D):	$0.09 | 6.88%
Avg Daily Range (90 D):	$0.10 | 5.08%

Institutional Daily Volume
Avg Daily Volume:	1.16M
Avg Daily Volume (30 D):	2.65M
Avg Daily Volume (90 D):	1.7M

Trade Size
Avg Trade Size (Sh.):	157
Avg Trade Size (Sh.) (30 D):	230
Avg Trade Size (Sh.) (90 D):	186

Institutional Trades
Total Institutional Trades:	308
Avg Institutional Trade:	$1.88M
Avg Institutional Trade (30 D):	$2.99M
Avg Institutional Trade (90 D):	$2.47M
Avg Institutional Trade Volume:	.28M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.4M
Avg Closing Trade (30 D):	$4.66M
Avg Closing Trade (90 D):	$4.66M
Avg Closing Volume:	360.59K

News

Jun 15, 2026 @ 12:00 PM Neumora Therapeutics Reports Data from Phase 3 KOA... Source: Na

Mar 19, 2026 @ 11:27 PM NMRA Investors Have Opportunity to Join Neumora Th... Source: Schall Law Firm

Mar 16, 2026 @ 11:00 AM Neumora Therapeutics to Report Fourth Quarter and ... Source: Na

Feb 4, 2026 @ 12:00 PM Neumora Therapeutics to Participate in Gugge... Source: Na

Nov 18, 2025 @ 6:02 PM Top 3 Biotech Stocks Capitalizing on the AI Revolu... Source: Timothy Fries

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.33	$-.3	$-.35
Diluted EPS	$-1.33	$-.3	$-.35
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-222.39M	$-53.46M	$-59.45M
Operating Income / Loss	$-223.08M	$-52.86M	$-58.48M
Cost of Revenue
Net Cash Flow	$3.71M	$-35.46M	$53.46M
PE Ratio